Qube Research & Technologies (QRT)
INDV icon

Qube Research & Technologies (QRT)’s Indivior Pharmaceuticals INDV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.1M Buy
+429,363
New +$14.2M 0.02% 1119
2025
Q2 		– Sell
-239,389
Closed -$2.28M – 3776
2025
Q1 		$2.28M Sell
239,389
-347,902
-59% -$3.66M ﹤0.01% 1903
2024
Q4 		$7.3M Buy
587,291
+314,142
+115% +$3.23M 0.01% 1285
2024
Q3 		$2.66M Buy
273,149
+270,474
+10,111% +$3.17M ﹤0.01% 1658
2024
Q2 		$43.1K Sell
2,675
-49,627
-95% -$896K ﹤0.01% 2772
2024
Q1 		$1.12M Buy
52,302
+32,616
+166% +$613K ﹤0.01% 2079
2023
Q4 		$301K Buy
19,686
+17,884
+992% +$318K ﹤0.01% 2574
2023
Q3 		$40.7K Buy
+1,802
New +$41.1K ﹤0.01% 2932

Other funds holding INDV

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return